|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
Laryngeal Cancer Screen 4 Tissue Microarray - LS-SLXCA4
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SLXCA4 |
| Product Name: |
Laryngeal Cancer Screen 4 |
| Description: |
Larynx and pharynx cancer with self-matching adjacent normal/non-neoplastic specimens |
| Format: |
FFPE |
| Category: |
Human Tumor and Matched Normal |
| QA/QC: |
H&E reviewed; IHC validated with a positive control antibody |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5 µm |
| Cases: |
10 |
| Cores: |
24 |
| Slides Per Set: |
1 |
LS-SLXCA4 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | | A | Lrx | Lrx | Lrx | Lrx | Lrx | Lrx | | B | Lrx | Lrx | Lrx | Lrx | Lrx | Lrx | | C | Pyx | Pyx | Pyx | Pyx | Nsl | Nsl | | D | Pyx | Pyx | Pyx | Pyx | Pyx | Pyx |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendLarynx (Lrx); Nasopharynx (Nsl); Pharynx (Pyx);
LS-SLXCA4 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade |
|---|
| 1 | A1 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | A2 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | A3 | Human | M | 71 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | A4 | Human | M | 71 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | A5 | Human | M | 62 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | A6 | Human | M | 62 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | B1 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | B2 | Human | M | 56 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | B3 | Human | M | 51 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | B4 | Human | M | 51 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | B5 | Human | M | 51 y | Larynx (Lrx) | Adjacent normal | Benign non-neoplastic | |
| 1 | B6 | Human | M | 51 y | Larynx (Lrx) | Adjacent normal | Benign non-neoplastic | |
| 1 | C1 | Human | M | 57 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | C2 | Human | M | 57 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade I |
| 1 | C3 | Human | M | 58 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | C4 | Human | M | 58 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | C5 | Human | F | 56 y | Nasopharynx (Nsl) | Squamous cell carcinoma | Malignant | Grade III |
| 1 | C6 | Human | F | 56 y | Nasopharynx (Nsl) | Squamous cell carcinoma | Malignant | Grade III |
| 1 | D1 | Human | F | 75 y | Pharynx (Pyx) | Acinic cell carcinoma | Malignant | |
| 1 | D2 | Human | F | 75 y | Pharynx (Pyx) | Acinic cell carcinoma | Malignant | |
| 1 | D3 | Human | M | 48 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | D4 | Human | M | 48 y | Pharynx (Pyx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | D5 | Human | M | 48 y | Pharynx (Pyx) | Adjacent normal | Benign non-neoplastic | |
| 1 | D6 | Human | M | 48 y | Pharynx (Pyx) | Adjacent normal | Benign non-neoplastic | |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
